Moving Beyond JAK Inhibitors in Myeloproliferative Neoplasms
2 Mga view
• 07/29/23
0
0
I-embed
administrator
Mga subscriber
Naveen Pemmaraju, MD, discusses the need to move beyond JAK inhibition when treating patients with myeloproliferative neoplasms.
Magpakita ng higit pa
Mga Komento sa Facebook
SORT BY-
Mga Nangungunang Komento
-
Pinakabagong komento